Leukemia and Insulin: No Direct Causal Link

Leukemia—a malignant proliferation of hematopoietic cells in the bone marrow—does not cause insulin overproduction (hyperinsulinemia). Insulin is synthesized exclusively by pancreatic β-cells; leukemic cells lack this capacity.

Actual Causes of Hyperinsulinemia

• Insulinoma: Pancreatic neuroendocrine tumor (usually benign) secreting insulin autonomously.
• Insulin resistance: Obesity, metabolic syndrome, PCOS, lipodystrophy — compensatory hyperinsulinemia.
• Exogenous insulin: Accidental or intentional overdose.
• Rare genetic disorders: Congenital hyperinsulinism (ABCC8, KCNJ11 mutations).
• Medications: Sulfonylureas, GLP-1 agonists, DPP-4 inhibitors (therapeutic effect).

Hypoglycemia in a Leukemia Patient — Think Differently

If a leukemia patient develops hypoglycemia, investigate:

• Chemotherapy-induced mucositis/anorexia → reduced intake.
• Sepsis (cytokine-mediated insulin sensitization).
• Adrenal insufficiency (steroid withdrawal, metastasis).
• Renal/hepatic failure (reduced gluconeogenesis, insulin clearance).
• Drug interactions (e.g., quinolones, pentamidine).
• Insulinoma (coincidental).

Leukemia itself is not on the differential for hyperinsulinemia. Treat the underlying cause of hypoglycemia.